北京协和中枢神经系统脱髓鞘疾病课件_第1页
北京协和中枢神经系统脱髓鞘疾病课件_第2页
北京协和中枢神经系统脱髓鞘疾病课件_第3页
北京协和中枢神经系统脱髓鞘疾病课件_第4页
北京协和中枢神经系统脱髓鞘疾病课件_第5页
已阅读5页,还剩127页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

北京协和中枢神经系统脱髓鞘疾病北京协和中枢神经系统脱髓鞘疾病MyelininCNSisformedbytheoligodendrocytesChemicalcomposition:proteolipid,myelinbasicprotein,2’-3’cyclicnucleotidephosphohydrolase,myelin-associatedglyco-protein,myelin-oligodendrocyteglyco-protein.MyelininCNSisformedbytheIntactmyelinisrequiredforactionpotentialconduction

IntactmyelinisrequiredforMyelinednervefiberarerichinwhitematterofcerebral、cerebella、brainstem、spinalcord,opticnerveMyelinednervefiberarerichDemyelinating——

myelinisbroken,

axonremainsintactDemyelinating——

DemelinateddisordersinCNSCongenitalobtainedleukodystrophyinflammatoryothersprimarysecondaryMSNMOADEMBalo’sDemelinateddisordersinCNSCoInflammatorydemyelinatingdisordersincentralnervesystemMultipleSclerosis(MS)1Neuromyelitisoptica(NMO)2AcuteDisseminatedEncephalomyelitis(ADEM)3Concentricsclerosis(Balo’sdisease)4InflammatorydemyelinatingdisInflammatorydemyelinatingdisordersInCNSMultipleSclerosis(MS)InflammatorydemyelinatingdisWhatisMultipleSclerosis?MultipleSclerosis(MS)“sclerosis”comesfromtheGreekword“skleros”,meaninghard.Inmultiplesclerosis,hardareascalled“plaques”.“Multiple”referstothemanydifferentareasofthenervoussystemthatmayhavedamagedmyelin.WhatisMultipleSclerosis?MulWhatisMultipleSclerosis?chronicinflammatorydiseaseofCNSmalfunctionoftheimmunesystemwhichleadstoattacksagainstmyelinsheathinsulatingmyelinisdamaged.Thelossofmyelininsulationdegradesthenervetransmissionability.Thusamultitudeofvariousneurologicaldisabilitiescanbeobservedinpatientsaffectedbythisdiseasedependingonwhichnervesaredamaged.WhatisMultipleSclerosis?chEpidemiologyapproximately1.1millionpeopleareaffectedinUSinallpartsoftheworldandinallraces,butwhitesofnorthernEuropeandescenthavethehighestincidence.occurinanyage.usuallydiagnosedinaged15-45years;averageageatdiagnosisis29yearsinwomenand31yearsinmen.femaletomaleratiois2:1.

EpidemiologysymptomsMSwasfirstdescribedbyCruveilhierin1835.AgenerallyvaliddescriptionofMSsymptomswasmadebyCharcotintheyear1868.In1904thedescriptionwassupplementedbyMüller.symptomsMSwasfirstdescribedMultifocallesionsMultifocallesionsMultifocallesionsMultifocallesionssymptomsCommonsymptoms:SensorydisturbanceWeaknessProblemsinwalking/balance/coordinationVisualproblems:opticnerveOtherpossiblesymptoms:BladderproblemSpasticityFatigueFacialweaknessTrigeminalneuralgiaslurredspeechtroubleswallowingDeafnesstemporaryblindnessCognitiveproblemsEpilepsyDepressionsymptomsCommonsymptoms:OthersignsLocalweaknessLocalsensorydisturbancespoorcoordinationofupperandlowerextremitymovements,wide-basedgaitwithinabilitytotandemwalk.

nystagmus,internuclearophthalmoplegia,visualdisturbances,palloroftheopticdisc,Lhermittesign,traversespinalmyelopathy,Brown-sequardsyndromeindifferentlevelsofspinalcordsignsLocalweaknessCourses(multiplephases)Courses(multiplephases)LaboratoryfindingsMagneticResonanceImaging(MRI)willshowpatchesoftissueCSF:WBC,protein,MBP,OB,specificAbsEvokedPotentials:visualevokedpotentials(VEP)auditoryevokedpotentials(BAEP)somatosensoryevokedpotentials(SEP)LaboratoryfindingsMagneticReHowismultiplesclerosisdiagnosed?Time——mutiplephasesSpace——mutifocallesionsExcludeothersHowismultiplesclerosisdiagTheDiagnosticCriteria

ofMS(Poser,1983)NumberofAttackEvidenceofMoreThanOneLesionClinicalLab.CSFOCBorIgGA.ClinicallyDefiniteB.Lab-SupportedDefiniteC.ClinicallyProbableD.Lab-SupportedProbableA122A221and1B121or1+B212+B311and1+C121C212C311and1D1200+TheDiagnosticCriteriaofMSDiagnosticCriteriaforMultipleSclerosis

(McDonaldCriteria,2001)(1)ClinicalPresentationAdditionalDataNeeded2ormoreattacks(relapses)2ormoreobjectiveclinicallesions

None;clinicalevidencewillsuffice

(additionalevidencedesirablebutmustbeconsistentwithMS)2ormoreattacks1objectiveclinicallesionDisseminationinspace,demonstratedby:

MRI

orapositiveCSFand2ormoreMRIlesionsconsistentwithMSorfurtherclinicalattackinvolvingdifferentsite1attack2ormoreobjectiveclinicallesionsDisseminationintime,demonstratedby:MRIorsecondclinicalattack1attack1objectiveclinicallesion(monosymptomaticpresentation)Disseminationinspacebydemonstratedby:MRIorpositiveCSFand2ormoreMRIlesionsconsistentwithMSandDisseminationintimedemonstratedby:MRIorsecondclinicalattackDiagnosticCriteriaforMultipDiagnosticCriteriaforMultipleSclerosis

(McDonaldCriteria,2001)(2)Insidiousneurologicalprogression

suggestiveofMS

(primaryprogressiveMS)

PositiveCSFand

Disseminationinspacedemonstratedby:MRIevidenceof9ormoreT2brainlesionsor2ormorespinalcordlesionsor4-8brainand1spinalcordlesionorpositiveVEPwith4-8MRIlesionsorpositiveVEPwith<4brainlesionsplus1spinalcordlesionand

Disseminationintimedemonstratedby:MRIorcontinuedprogressionfor1year

DiagnosticCriteriaforMultip北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件DifferentialdiagnosisFirstattack:singlelesionormultiplelesions:infection,tumor,infarction,Relapsetype:infarction,embolism,vasculitis,Progressive:

inherited,degenerating,DifferentialdiagnosisFirstatPathologyofMSGrossneuropathologygreyplaques(acuteplaquemaybepink)mayoccuranywhereMicroscopicneuropathologyperivascularlymphocytesinfiltrate;lossofoligodendrocytes;myelinstripping;macrophageinfiltrate;astrogliosis;relativesparingofaxonsPathologyofMSGrossneuropath北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件WhatCausesMS?TheexactcauseofMSisnotknownEnvironmentalFactors:

Geographyisclearlyanimportantfactortherateisapproximatelytwiceasbelowthe37thparallel.GeneticFactors:

MSisnotstrictlyaninheriteddisorder.SusceptibilitytoMSprobablyhasageneticcomponent.

WhatCausesMS?TheexactcausePathogenesisofMS:incompletelyunderstood.Immune-mediateddisorder

withan

initialtrigger

Molecularmimicry

OligodendrocytesusceptibleCNSinfectionsmayalsoleadtothetransmigrationofactivatedTlymphocytesintotheCNS,whichinitiatetheprocessPathogenesisofMS:incompleteHowisMSTreated?ImmunotherapyCorticosteroidscorticosteroidscanreducethedurationofsymptoms,theydonotcureMS.UsedinAcuteattacks

intravenousmethylprednisolone1000mgdailyforthreedays.

Prednisone:Cliniciansdifferonwhethertotaperofftreatmentwithoralprednisonefortwoweeks,butthisprobablydoesnotimproveresultsandincreasessideeffects.HowisMSTreated?ImmunotherapInterferons

Betainterferondrugshaveshowntobeeffectiveintreatingtherelapsing-remittingtypeofMS.InterferonsImmunosuppressantsmethotrexate,cyclophosphamide,cyclosporine,mitoxantrone.OthersIvIgplasmaexchangeImmunosuppressantsSymptomaticmanagementBladderfrequencyandurgencywilloftenrespondtooxybutynin.Painandspasmsfromspasticlimbsusuallyrespondtobaclofen.Emotionallabilitywithpathologicallaughingorcryingcanbemanagedwithatricyclicantidepressant.Amantadinereducesfatigueinhalfthepatients.Moredifficulttomanagearepain,sexualdysfunction,weakness,dysesthesiaandothersensorysymptoms,tremor,ataxia,andcognitivechange,buteventhesemayrespondtovarioustherapeuticapproaches.Itisimportanttorecognisethathalfofpatientswithmultiplesclerosiswillbecomedepressedandthattherapyandcounsellingmaybenecessary.SymptomaticmanagementPrognosisMortality/Morbidity:

LifeexpectancyisshortenedonlyslightlywithMS,andthesurvivalrateislinkedtodisability.Usually,deathisduetosecondarycomplications(50-66%),suchaspulmonaryorrenalcauses,suicide,primarycomplications,andcausesotherthanMSseeninthegeneralpopulation.PrognosisMortality/Morbidity:InflammatorydemyelinatingdisordersinCNS

Neuromyelitisoptica(NMO)InflammatorydemyelinatingdisSimilaritieswithMSmutifocallesionsmutiplephasesimmuno-mediatedinflammatorydemyelinationinCNSSimilaritieswithMSmutifocalDifferenceswithMS

----mutifocallesionsMyelitis:longlesion≧3vertebralsegments.Optisneuritis:Brainlesions:atypicalforMS.Multiplephases:morefrequentlyarelapsing-remittingcourse.DifferenceswithMS

----mutif北京协和中枢神经系统脱髓鞘疾病课件OpticnerveatrophyOpticnerveatrophy北京协和中枢神经系统脱髓鞘疾病课件DifferenceswithMS

----PathologicalfeaturesofNMOdemyelinationandnecrosisprominentvascularfibrosisandhyalinizationwithinthelesionsperivasculardepositionofIgGandcomplementperivascularinfiltratesofpolymorphonuclearcells,leucocytes,plasmacells,eosinophilsglialscarsarelessfrequentandusuallyonlypartialincontrasttotypicalMSlesionsDifferenceswithMS

----PathDifferenceswithMS

----pathogenesisofNMOhumoralimmunitytargetantigenisaquaporin-4,thedominantwaterchannelin(CNS)IgG-antibodytoaquaporin-4,namedNMO-IgGDifferenceswithMS

----pathDiagnositiccriteriaforNMODiagnositiccriteriaforNMODifferentialdiagnosisIschemiaofopticnerveAcutemyelitisVasculardiseaseofthespinalcordVasculitisConnectivetissuediseaseDifferentialdiagnosisIschemiaDifferenceswithMS

----Treatmentacutephase:intravenoussteroidsandplasmaexchangetherapy.Topreventrelapse:oralsteroidmedicationandimmunosuppressivedrugs.DifferenceswithMS

----TreatInflammatorydemyelinatingdisordersinCNSAcuteDisseminatedEncephalomyelitis(ADEM)InflammatorydemyelinatingdisAcuteDisseminatedEncephalomyelitisQuiterapidinonset,oftengettingsickoveraperiodofafewdaysMultifocalneurologicaldysfunction,involvingbrain、spinalcord、meningesMRI:multifocallesionsinCNSCSF:WBCcountnormalormildelevated,immuneproteinslevelelevatedGoodresponsetotherapy:corticosteroidtreatmentsPrecipitatingEvents:recentinfectionsandcertainrecentvaccinations,certainmedications,trauma,idiopathic

MostADEMaremonophasic,someareMDEM(multiphasicDisseminatedEncephalomyelitis),ordeveloptoMSAcuteDisseminatedEncephalomy北京协和中枢神经系统脱髓鞘疾病课件InflammatorydemyelinatingdisordersinCNS

Concentricsclerosis(Balo’sdisease)InflammatorydemyelinatingdisConcentricsclerosis(Balo’s)Balodisease(concentricsclerosis)isararevariantofinflammatorydemyelinatingdiseaseDiagnosisismadeuponbiopsywhichshowsalternatingbandsofmyelinatinganddemyelinatingfibersinwhitematter.

Monophasic,non-remittingConcentricsclerosis(Balo’s)B北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件OtherdemyelinatingdisordersProgressivemutifocalleukoencephalopathyCentralpontinemyelinolysisMarchiafava-BignamidiseaseToxicdemyelination:chemicalagents,COIrradiationencephalopathyCerebralvasculardiseaseOtherdemyelinatingdisordersPOtherdemyelinatingdisorders

Centralpontinemyelinolysis,CPMOtherdemyelinatingdisorders

Centralpontinemyelinolysis,CPMCentralpontinemyelinolysis(CPM)isanuncommonconsequence

ofcertainmetabolicderangements.Theseincluderapidcorrection

ofhyponatremia,aswellashyperosmolarconditions,suchas

hyperglycemia.ThemicroscopicappearanceofCPMislossof

myelinwithsparingofaxons,withoutevidenceofinflammation

.Centralpontinemyelinolysis,COtherdemyelinatingdisorders

Progressivemultifocalleukoencephalopathy(PML)Itisademyelinatingdiseasecausesbyapolyomavirus(theJCvirus).TheJCviruspreferentiallyinfectsoligodendrocytes,thusdemyelinationinCNS.immunosuppressedpatientsandAIDSpatients,areatrisk.Neurologicsymptomsdependonthelocationofthelesionsrelentlesslyprogressive.Otherdemyelinatingdisorders北京协和中枢神经系统脱髓鞘疾病课件Otherdemyelinatingdisorders

DelayedEncephalopathyofAcuteCarbonMonoxideIntoxicationOtherdemyelinatingdisordersOtherdemyelinatingdisorders

Marchiafava-BignamidiseaseOtherdemyelinatingdisordersleukodystrophyinheriteddysmyelinatingdiseaseadrenoleukodystrophy

metachromaticleukodystrophy

spongydegeneration(Canavandisease)

globoidcell(Krabbe)leukodystrophy

Alexanderdisease

Pelizaeus-Merzbacherdisease

Cockaynesyndrome

leukodystrophyinheriteddysmyeadrenoleukodystrophyX-linkedrecessivedemyelinationofcerebralwhitematteradrenalinsufficiency(unresponsivetoACTH)CT:white-matterdz:occipitalregions-->frontalprogression-->generalizedatrophyMRI:hypointenseT1/hyperintenseT2,atrophicspleniumofcorpuscallosumadrenoleukodystrophyX-linkedrmetachromaticleukodystrophydymyelinatingdisease

autosomalrecessivearylsulfataseA--absentfromurineandserummostpresentby2yrs,dieat3-4yrsmayariseatanyageMR:hypointenseT1/hyperintenseT2,ofwhitematter,primarilyincentrumsemiovale

metachromaticleukodystrophydmetachromaticleukodystrophymetachromaticleukodystrophy北京协和中枢神经系统脱髓鞘疾病北京协和中枢神经系统脱髓鞘疾病MyelininCNSisformedbytheoligodendrocytesChemicalcomposition:proteolipid,myelinbasicprotein,2’-3’cyclicnucleotidephosphohydrolase,myelin-associatedglyco-protein,myelin-oligodendrocyteglyco-protein.MyelininCNSisformedbytheIntactmyelinisrequiredforactionpotentialconduction

IntactmyelinisrequiredforMyelinednervefiberarerichinwhitematterofcerebral、cerebella、brainstem、spinalcord,opticnerveMyelinednervefiberarerichDemyelinating——

myelinisbroken,

axonremainsintactDemyelinating——

DemelinateddisordersinCNSCongenitalobtainedleukodystrophyinflammatoryothersprimarysecondaryMSNMOADEMBalo’sDemelinateddisordersinCNSCoInflammatorydemyelinatingdisordersincentralnervesystemMultipleSclerosis(MS)1Neuromyelitisoptica(NMO)2AcuteDisseminatedEncephalomyelitis(ADEM)3Concentricsclerosis(Balo’sdisease)4InflammatorydemyelinatingdisInflammatorydemyelinatingdisordersInCNSMultipleSclerosis(MS)InflammatorydemyelinatingdisWhatisMultipleSclerosis?MultipleSclerosis(MS)“sclerosis”comesfromtheGreekword“skleros”,meaninghard.Inmultiplesclerosis,hardareascalled“plaques”.“Multiple”referstothemanydifferentareasofthenervoussystemthatmayhavedamagedmyelin.WhatisMultipleSclerosis?MulWhatisMultipleSclerosis?chronicinflammatorydiseaseofCNSmalfunctionoftheimmunesystemwhichleadstoattacksagainstmyelinsheathinsulatingmyelinisdamaged.Thelossofmyelininsulationdegradesthenervetransmissionability.Thusamultitudeofvariousneurologicaldisabilitiescanbeobservedinpatientsaffectedbythisdiseasedependingonwhichnervesaredamaged.WhatisMultipleSclerosis?chEpidemiologyapproximately1.1millionpeopleareaffectedinUSinallpartsoftheworldandinallraces,butwhitesofnorthernEuropeandescenthavethehighestincidence.occurinanyage.usuallydiagnosedinaged15-45years;averageageatdiagnosisis29yearsinwomenand31yearsinmen.femaletomaleratiois2:1.

EpidemiologysymptomsMSwasfirstdescribedbyCruveilhierin1835.AgenerallyvaliddescriptionofMSsymptomswasmadebyCharcotintheyear1868.In1904thedescriptionwassupplementedbyMüller.symptomsMSwasfirstdescribedMultifocallesionsMultifocallesionsMultifocallesionsMultifocallesionssymptomsCommonsymptoms:SensorydisturbanceWeaknessProblemsinwalking/balance/coordinationVisualproblems:opticnerveOtherpossiblesymptoms:BladderproblemSpasticityFatigueFacialweaknessTrigeminalneuralgiaslurredspeechtroubleswallowingDeafnesstemporaryblindnessCognitiveproblemsEpilepsyDepressionsymptomsCommonsymptoms:OthersignsLocalweaknessLocalsensorydisturbancespoorcoordinationofupperandlowerextremitymovements,wide-basedgaitwithinabilitytotandemwalk.

nystagmus,internuclearophthalmoplegia,visualdisturbances,palloroftheopticdisc,Lhermittesign,traversespinalmyelopathy,Brown-sequardsyndromeindifferentlevelsofspinalcordsignsLocalweaknessCourses(multiplephases)Courses(multiplephases)LaboratoryfindingsMagneticResonanceImaging(MRI)willshowpatchesoftissueCSF:WBC,protein,MBP,OB,specificAbsEvokedPotentials:visualevokedpotentials(VEP)auditoryevokedpotentials(BAEP)somatosensoryevokedpotentials(SEP)LaboratoryfindingsMagneticReHowismultiplesclerosisdiagnosed?Time——mutiplephasesSpace——mutifocallesionsExcludeothersHowismultiplesclerosisdiagTheDiagnosticCriteria

ofMS(Poser,1983)NumberofAttackEvidenceofMoreThanOneLesionClinicalLab.CSFOCBorIgGA.ClinicallyDefiniteB.Lab-SupportedDefiniteC.ClinicallyProbableD.Lab-SupportedProbableA122A221and1B121or1+B212+B311and1+C121C212C311and1D1200+TheDiagnosticCriteriaofMSDiagnosticCriteriaforMultipleSclerosis

(McDonaldCriteria,2001)(1)ClinicalPresentationAdditionalDataNeeded2ormoreattacks(relapses)2ormoreobjectiveclinicallesions

None;clinicalevidencewillsuffice

(additionalevidencedesirablebutmustbeconsistentwithMS)2ormoreattacks1objectiveclinicallesionDisseminationinspace,demonstratedby:

MRI

orapositiveCSFand2ormoreMRIlesionsconsistentwithMSorfurtherclinicalattackinvolvingdifferentsite1attack2ormoreobjectiveclinicallesionsDisseminationintime,demonstratedby:MRIorsecondclinicalattack1attack1objectiveclinicallesion(monosymptomaticpresentation)Disseminationinspacebydemonstratedby:MRIorpositiveCSFand2ormoreMRIlesionsconsistentwithMSandDisseminationintimedemonstratedby:MRIorsecondclinicalattackDiagnosticCriteriaforMultipDiagnosticCriteriaforMultipleSclerosis

(McDonaldCriteria,2001)(2)Insidiousneurologicalprogression

suggestiveofMS

(primaryprogressiveMS)

PositiveCSFand

Disseminationinspacedemonstratedby:MRIevidenceof9ormoreT2brainlesionsor2ormorespinalcordlesionsor4-8brainand1spinalcordlesionorpositiveVEPwith4-8MRIlesionsorpositiveVEPwith<4brainlesionsplus1spinalcordlesionand

Disseminationintimedemonstratedby:MRIorcontinuedprogressionfor1year

DiagnosticCriteriaforMultip北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件DifferentialdiagnosisFirstattack:singlelesionormultiplelesions:infection,tumor,infarction,Relapsetype:infarction,embolism,vasculitis,Progressive:

inherited,degenerating,DifferentialdiagnosisFirstatPathologyofMSGrossneuropathologygreyplaques(acuteplaquemaybepink)mayoccuranywhereMicroscopicneuropathologyperivascularlymphocytesinfiltrate;lossofoligodendrocytes;myelinstripping;macrophageinfiltrate;astrogliosis;relativesparingofaxonsPathologyofMSGrossneuropath北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件北京协和中枢神经系统脱髓鞘疾病课件WhatCausesMS?TheexactcauseofMSisnotknownEnvironmentalFactors:

Geographyisclearlyanimportantfactortherateisapproximatelytwiceasbelowthe37thparallel.GeneticFactors:

MSisnotstrictlyaninheriteddisorder.SusceptibilitytoMSprobablyhasageneticcomponent.

WhatCausesMS?TheexactcausePathogenesisofMS:incompletelyunderstood.Immune-mediateddisorder

withan

initialtrigger

Molecularmimicry

OligodendrocytesusceptibleCNSinfectionsmayalsoleadtothetransmigrationofactivatedTlymphocytesintotheCNS,whichinitiatetheprocessPathogenesisofMS:incompleteHowisMSTreated?ImmunotherapyCorticosteroidscorticosteroidscanreducethedurationofsymptoms,theydonotcureMS.UsedinAcuteattacks

intravenousmethylprednisolone1000mgdailyforthreedays.

Prednisone:Cliniciansdifferonwhethertotaperofftreatmentwithoralprednisonefortwoweeks,butthisprobablydoesnotimproveresultsandincreasessideeffects.HowisMSTreated?ImmunotherapInterferons

Betainterferondrugshaveshowntobeeffectiveintreatingtherelapsing-remittingtypeofMS.InterferonsImmunosuppressantsmethotrexate,cyclophosphamide,cyclosporine,mitoxantrone.OthersIvIgplasmaexchangeImmunosuppressantsSymptomaticmanagementBladderfrequencyandurgencywilloftenrespondtooxybutynin.Painandspasmsfromspasticlimbsusuallyrespondtobaclofen.Emotionallabilitywithpathologicallaughingorcryingcanbemanagedwithatricyclicantidepressant.Amantadinereducesfatigueinhalfthepatients.Moredifficulttomanagearepain,sexualdysfunction,weakness,dysesthesiaandothersensorysymptoms,tremor,ataxia,andcognitivechange,buteventhesemayrespondtovarioustherapeuticapproaches.Itisimportanttorecognisethathalfofpatientswithmultiplesclerosiswillbecomedepressedandthattherapyandcounsellingmaybenecessary.SymptomaticmanagementPrognosisMortality/Morbidity:

LifeexpectancyisshortenedonlyslightlywithMS,andthesurvivalrateislinkedtodisability.Usually,deathisduetosecondarycomplications(50-66%),suchaspulmonaryorrenalcauses,suicide,primarycomplications,andcausesotherthanMSseeninthegeneralpopulation.PrognosisMortality/Morbidity:InflammatorydemyelinatingdisordersinCNS

Neuromyelitisoptica(NMO)InflammatorydemyelinatingdisSimilaritieswithMSmutifocallesionsmutiplephasesimmuno-mediatedinflammatorydemyelinationinCNSSimilaritieswithMSmutifocalDifferenceswithMS

----mutifocallesionsMyelitis:longlesion≧3vertebralsegments.Optisneuritis:Brainlesions:atypicalforMS.Multiplephases:morefrequentlyarelapsing-remittingcourse.DifferenceswithMS

----mutif北京协和中枢神经系统脱髓鞘疾病课件OpticnerveatrophyOpticnerveatrophy北京协和中枢神经系统脱髓鞘疾病课件DifferenceswithMS

----PathologicalfeaturesofNMOdemyelinationandnecrosisprominentvascularfibrosisandhyalinizationwithinthelesionsperivasculardepositionofIgGandcomplementperivascularinfiltratesofpolymorphonuclearcells,leucocytes,plasmacells,eosinophilsglialscarsarelessfrequentandusuallyonlypartialincontrasttotypicalMSlesionsDifferenceswithMS

----PathDifferenceswithMS

----pathogenesisofNMOhumoralimmunitytargetantigenisaquaporin-4,thedominantwaterchannelin(CNS)IgG-antibodytoaquaporin-4,namedNMO-IgGDifferenceswithMS

----pathDiagnositiccriteriaforNMODiagnositiccriteriaforNMODifferentialdiagnosisIschemiaofopticnerveAcutemyelitisVasculardiseaseofthespinalcordVasculitisConnectivetissuediseaseDifferentialdiagnosisIschemiaDifferenceswithMS

----Treatmentacutephase:intravenoussteroidsandplasmaexchangetherapy.Topreventrelapse:oralsteroidmedicationandimmunosuppressivedrugs.DifferenceswithMS

----TreatInflammatorydemyelinatingdisordersinCNSAcuteDisseminatedEncephalomyelitis(ADEM)InflammatorydemyelinatingdisAcuteDisseminatedEncephalomyelitisQuiterapidinonset,oftengettingsickoveraperiodofafewdaysMultifocalneurologicaldysfunction,involvingbrain、spinalcord、meningesMRI:multifocallesionsinCNSCSF:WBCcountnormalormildelevated,immuneproteinslevelelevatedGoodresponsetotherapy:corticosteroidtreatmentsPrecipitatingEvents:recentinfectionsandcertainrecentvaccinations,certainmedications,trauma,idiopathic

MostADEMaremonophasic,someare

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论